Description
NYBC Ventures, a part of New York Blood Center Enterprises, is a venture fund dedicated to accelerating innovation in blood-related fields and cellular therapies and technology. NYBC established the fund with a $50M investment and a mission to improve patients’ lives by advancing therapeutics, enabling platforms and technologies, and driving collaborations to further NYBC’s impact. We invest in mission-driven therapeutics, devices, and innovative technologies, addressing the most pressing challenges in our area of focus: cell therapy, transfusion medicine, infectious diseases, and benign hematology. Visit our website to learn more and connect with us! Or connect with us through LinkedIn.
